Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1511503

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1511503

Asia Pacific Rabeprazole Sodium Market Size, Share & Trends Analysis Report By Age, By Distribution Channel (Drug & Retail Store Pharmacies, Hospital Pharmacies and Online Pharmacies), By Application, By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 99 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Multi User License)
USD 1800
PDF (Corporate User License)
USD 2520

Add to Cart

The Asia Pacific Rabeprazole Sodium Market would witness market growth of 4.5% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Rabeprazole Sodium Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $63,672.4 Thousands by 2031. Japan market is showcasing a CAGR of 3.8% during (2024 - 2031). Additionally, The India market would register a CAGR of 5.2% during (2024 - 2031).

As per the World Health Organisation (WHO), the prevalence of H. pylori infection varies across various regions and demographic groups, affecting over half of the global population. In developing economies, the prevalence of H. pylori is higher due to factors like inadequate healthcare infrastructure, congested living conditions, and poor hygiene practices.

Moreover, which may result in limited access to sanitation and healthcare. These conditions create fertile grounds for bacterial transmission and persistent infection, contributing to the burden of gastrointestinal diseases in these populations.

The Asia Pacific region's market is experiencing substantial growth as a result of changing dietary habits, accelerated urbanization, and rising prevalence of gastrointestinal disorders, as well as improvements in healthcare infrastructure. In countries across Asia, such as India and China, where healthcare affordability is critical, the introduction of generic rabeprazole sodium has been particularly impactful. Local pharmaceutical companies have capitalized on the opportunity to produce cost-effective generics, expanding access to essential gastrointestinal treatments for millions of patients.

Based on Age, the market is segmented into Below 55 years and Above 55 years. Based on Distribution Channel, the market is segmented into Drug & Retail Store Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on Application, the market is segmented into Gastroesophageal Reflux Disease, Peptic Ulcer and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Cadila Pharmaceuticals Ltd
  • Alembic Pharmaceuticals Ltd
  • Woodward Pharma
  • Elikem Pharmaceuticals Pvt Ltd
  • Jasco Labs Private Limited
  • Torrent Pharmaceuticals Ltd.

Asia Pacific Rabeprazole Sodium Market Report Segmentation

By Age

  • Below 55 years and
  • Above 55 years

By Distribution Channel

  • Drug & Retail Store Pharmacies,
  • Hospital Pharmacies and
  • Online Pharmacies

By Application

  • Gastroesophageal Reflux Disease,
  • Peptic Ulcer and
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Rabeprazole Sodium Market, by Age
    • 1.4.2 Asia Pacific Rabeprazole Sodium Market, by Distribution Channel
    • 1.4.3 Asia Pacific Rabeprazole Sodium Market, by Application
    • 1.4.4 Asia Pacific Rabeprazole Sodium Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Asia Pacific Rabeprazole Sodium Market by Age

  • 4.1 Asia Pacific Below 55 years Market by Country
  • 4.2 Asia Pacific Above 55 years Market by Country

Chapter 5. Asia Pacific Rabeprazole Sodium Market by Distribution Channel

  • 5.1 Asia Pacific Drug & Retail Store Pharmacies Market by Country
  • 5.2 Asia Pacific Hospital Pharmacies Market by Country
  • 5.3 Asia Pacific Online Pharmacies Market by Country

Chapter 6. Asia Pacific Rabeprazole Sodium Market by Application

  • 6.1 Asia Pacific Gastroesophageal Reflux Disease Market by Country
  • 6.2 Asia Pacific Peptic Ulcer Market by Country
  • 6.3 Asia Pacific Others Market by Country

Chapter 7. Asia Pacific Rabeprazole Sodium Market by Country

  • 7.1 China Rabeprazole Sodium Market
    • 7.1.1 China Rabeprazole Sodium Market by Age
    • 7.1.2 China Rabeprazole Sodium Market by Distribution Channel
    • 7.1.3 China Rabeprazole Sodium Market by Application
  • 7.2 Japan Rabeprazole Sodium Market
    • 7.2.1 Japan Rabeprazole Sodium Market by Age
    • 7.2.2 Japan Rabeprazole Sodium Market by Distribution Channel
    • 7.2.3 Japan Rabeprazole Sodium Market by Application
  • 7.3 India Rabeprazole Sodium Market
    • 7.3.1 India Rabeprazole Sodium Market by Age
    • 7.3.2 India Rabeprazole Sodium Market by Distribution Channel
    • 7.3.3 India Rabeprazole Sodium Market by Application
  • 7.4 South Korea Rabeprazole Sodium Market
    • 7.4.1 South Korea Rabeprazole Sodium Market by Age
    • 7.4.2 South Korea Rabeprazole Sodium Market by Distribution Channel
    • 7.4.3 South Korea Rabeprazole Sodium Market by Application
  • 7.5 Singapore Rabeprazole Sodium Market
    • 7.5.1 Singapore Rabeprazole Sodium Market by Age
    • 7.5.2 Singapore Rabeprazole Sodium Market by Distribution Channel
    • 7.5.3 Singapore Rabeprazole Sodium Market by Application
  • 7.6 Malaysia Rabeprazole Sodium Market
    • 7.6.1 Malaysia Rabeprazole Sodium Market by Age
    • 7.6.2 Malaysia Rabeprazole Sodium Market by Distribution Channel
    • 7.6.3 Malaysia Rabeprazole Sodium Market by Application
  • 7.7 Rest of Asia Pacific Rabeprazole Sodium Market
    • 7.7.1 Rest of Asia Pacific Rabeprazole Sodium Market by Age
    • 7.7.2 Rest of Asia Pacific Rabeprazole Sodium Market by Distribution Channel
    • 7.7.3 Rest of Asia Pacific Rabeprazole Sodium Market by Application

Chapter 8. Company Profiles

  • 8.1 Cadila Pharmaceutical Limited
    • 8.1.1 Company Overview
  • 8.2 Alembic Pharmaceuticals Ltd. (Alembic Group)
    • 8.2.1 Company Overview
  • 8.3 Woodward Pharma Services
    • 8.3.1 Company Overview
  • 8.4 Elikem Pharmaceuticals Pvt. Ltd.
    • 8.4.1 Company Overview
  • 8.5 Jasco Labs Pvt Ltd
    • 8.5.1 Company Overview
  • 8.6 Torrent Pharmaceuticals Ltd.
    • 8.6.1 Company Overview
  • 8.7 Cipla Limited
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 SWOT Analysis
  • 8.8 Sun Pharmaceutical Industries Ltd.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Regional Analysis
    • 8.8.4 Research & Development Expenses
    • 8.8.5 SWOT Analysis
  • 8.9 Intas Pharmaceutical Ltd.
    • 8.9.1 Company Overview
  • 8.10. Dr. Reddy's Laboratories Ltd.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 SWOT Analysis

LIST OF TABLES

  • TABLE 1 Asia Pacific Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
  • TABLE 2 Asia Pacific Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
  • TABLE 3 Asia Pacific Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
  • TABLE 4 Asia Pacific Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
  • TABLE 5 Asia Pacific Below 55 years Market by Country, 2020 - 2023, USD Thousands
  • TABLE 6 Asia Pacific Below 55 years Market by Country, 2024 - 2031, USD Thousands
  • TABLE 7 Asia Pacific Above 55 years Market by Country, 2020 - 2023, USD Thousands
  • TABLE 8 Asia Pacific Above 55 years Market by Country, 2024 - 2031, USD Thousands
  • TABLE 9 Asia Pacific Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 10 Asia Pacific Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 11 Asia Pacific Drug & Retail Store Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 12 Asia Pacific Drug & Retail Store Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 13 Asia Pacific Hospital Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 14 Asia Pacific Hospital Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 15 Asia Pacific Online Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 16 Asia Pacific Online Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 17 Asia Pacific Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
  • TABLE 18 Asia Pacific Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
  • TABLE 19 Asia Pacific Gastroesophageal Reflux Disease Market by Country, 2020 - 2023, USD Thousands
  • TABLE 20 Asia Pacific Gastroesophageal Reflux Disease Market by Country, 2024 - 2031, USD Thousands
  • TABLE 21 Asia Pacific Peptic Ulcer Market by Country, 2020 - 2023, USD Thousands
  • TABLE 22 Asia Pacific Peptic Ulcer Market by Country, 2024 - 2031, USD Thousands
  • TABLE 23 Asia Pacific Others Market by Country, 2020 - 2023, USD Thousands
  • TABLE 24 Asia Pacific Others Market by Country, 2024 - 2031, USD Thousands
  • TABLE 25 Asia Pacific Rabeprazole Sodium Market by Country, 2020 - 2023, USD Thousands
  • TABLE 26 Asia Pacific Rabeprazole Sodium Market by Country, 2024 - 2031, USD Thousands
  • TABLE 27 China Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
  • TABLE 28 China Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
  • TABLE 29 China Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
  • TABLE 30 China Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
  • TABLE 31 China Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 32 China Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 33 China Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
  • TABLE 34 China Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
  • TABLE 35 Japan Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
  • TABLE 36 Japan Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
  • TABLE 37 Japan Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
  • TABLE 38 Japan Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
  • TABLE 39 Japan Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 40 Japan Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 41 Japan Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
  • TABLE 42 Japan Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
  • TABLE 43 India Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
  • TABLE 44 India Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
  • TABLE 45 India Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
  • TABLE 46 India Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
  • TABLE 47 India Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 48 India Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 49 India Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
  • TABLE 50 India Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
  • TABLE 51 South Korea Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
  • TABLE 52 South Korea Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
  • TABLE 53 South Korea Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
  • TABLE 54 South Korea Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
  • TABLE 55 South Korea Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 56 South Korea Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 57 South Korea Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
  • TABLE 58 South Korea Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
  • TABLE 59 Singapore Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
  • TABLE 60 Singapore Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
  • TABLE 61 Singapore Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
  • TABLE 62 Singapore Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
  • TABLE 63 Singapore Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 64 Singapore Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 65 Singapore Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
  • TABLE 66 Singapore Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
  • TABLE 67 Malaysia Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
  • TABLE 68 Malaysia Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
  • TABLE 69 Malaysia Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
  • TABLE 70 Malaysia Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
  • TABLE 71 Malaysia Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 72 Malaysia Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 73 Malaysia Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
  • TABLE 74 Malaysia Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
  • TABLE 75 Rest of Asia Pacific Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
  • TABLE 76 Rest of Asia Pacific Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
  • TABLE 77 Rest of Asia Pacific Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
  • TABLE 78 Rest of Asia Pacific Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
  • TABLE 79 Rest of Asia Pacific Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 80 Rest of Asia Pacific Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 81 Rest of Asia Pacific Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
  • TABLE 82 Rest of Asia Pacific Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
  • TABLE 83 Key Information -Cadila Pharmaceutical LimitedXX
  • TABLE 84 Key Information - Alembic Pharmaceuticals Ltd.
  • TABLE 85 Key Information - Woodward Pharma Services
  • TABLE 86 Key Information - Elikem Pharmaceuticals Pvt. Ltd.
  • TABLE 87 Key Information - Jasco Labs Pvt. Ltd.
  • TABLE 88 Key Information - Torrent Pharmaceuticals Ltd.
  • TABLE 89 Key Information - Cipla Limited
  • TABLE 90 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 91 Key Information - Intas Pharmaceutical Ltd.
  • TABLE 92 Key Information - Dr. Reddy's Laboratories Ltd.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!